振德醫療(603301.SH)2021年度淨利潤同比預降75.64%-77.21%
格隆匯1月28日丨振德醫療(603301.SH)公佈,公司預計2021年度實現歸屬於上市公司股東的淨利潤5.81億元至6.21億元,與上年同期相比預計減少19.28億元至19.68億元,同比減少75.64%到77.21%,但較2019年度增加270.32%至295.82%。
公司預計2021年度實現歸屬於上市公司股東的扣除非經常性損益的淨利潤4.81億元至5.21億元,與上年同期相比預計減少19.97億元至20.37億元,同比減少79.31%到80.90%,但較2019年度增加353.78%至391.51%。
公司2021年度經營業績較上年同期減少,主要原因繫上年同期受疫情影響,公司防疫類防護用品銷售大幅度提升,公司上年同期業績大幅度增長。但隨着國內疫情取得有效控制、國內外防疫類防護用品產品產能供應相對充足,防疫類防護用品價格迴歸,公司2021年度防疫類防護用品產品銷售收入、毛利率和產生的利潤均有所下降,敬請廣大投資者注意投資風險。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.